GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Profiles / Maria Luísa Lobo da Costa
Maria Luísa Lobo
  • +351 213 652 600
  • +351 213 632 105
  • Send Mail
  • Download CV
  • Orcid
  • NOVA Research

Maria Luísa Lobo da Costa

Post-Doc Fellow

GHTM Group: TB, HIV and opportunistic diseases and pathogens, THOP PhD members

ResearchTop 5 Publications

ML Lobo have started her scientific career developing research on human and animal microsporidiosis epidemiology in Portugal, that generated pioneering data on this area in the country, including the identification of a new species of microsporidia among the Portuguese population. Over time she has been expanding her scientific abilities and skills with several training/courses activities, including a intensive training on parasitological and molecular methodologies at Centers for Disease Control and Prevention (CDC), Atlanta, USA. Since then, the applicant developed several research, teaching and diagnosis (parasitological, immunological and molecular) activities in the Infectious Diseases/Medical Parasitology area. The opportunistic parasites Toxoplasma gondii, Microsporidia, Cryptosporidium spp., Pneumocystis jirovecii are among the parasites studied. Also, ML Lobo carries out the diagnosis of the following diseases: Malaria (parasitological, serological and molecular biology methods); Dengue, Zika and Chikungunya (serological methods), intestinal protozoa (Giardia duodenalis, Entamoeba histolytica, Cyclospora cayetanensis, and Cystoisospora belli) (parasitological, serological, culture, and molecular biology methods); human American tripanosomiasis (parasitological, serological and molecular  biology methods);

The researcher interests and professional aspirations primarily involve the research and education in the areas of Opportunistic Protists, Molecular and Cell Biology, Molecular Epidemiology, Immunology, Bioinformatics analysis, Infectious Diseases and Tropical Medicine. ML Lobo short-term career objectives intend consolidate partnerships with additional international and national Institutions of interest; exchanging technology and knowhow and promoting peer networking and data exchange on her main working area. Moreover, in the future aims of the researcher are included to carry out research projects whose main goal is the development, implementation and validation of new point-of-care diagnostic tests based on high-throughput technology (e.g. using biomarkers, molecular targets and/or nanotechnology) for the early detection of the above referred pathogens. Additionally, ML Lobo intends to assess opportunistic infections in migrants and travelers and promote an early detection and management of imported diseases and to expand cooperation for public health development in low-income environments associated with parasites.

  1. Lobo ML, Patrocinio G, Sevivas T, De Sousa B e Matos O. Portugal and Angola: similarities and differences in Toxoplasma gondii seroprevalence and risk factors among pregnant women. Epidemiology and Infection. January 2017; 145 (1): 30-40. doi: 10.1017/S0950268816001904 [FI= 2.515]
  2. Lobo ML, Augusto J, Antunes F, Ceita J, Xiao L, Codices V, Matos O. Cryptosporidium, Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Democratic Republic of São Tomé and Principe. PLOS ONE. 2014; 9(5): e97708. doi: 10.1371/journal.pone.0097708 [FI= 3.534 3.730; Times cited- 5]
  3. Lobo ML, Esteves F, Sousa B. Cardoso F, Cushion MT, Antunes F, Matos O. Therapeutic potential of Caspofungin combined with Trimethoprim-Sulfamethoxazole for Pneumocystis pneumonia: a pilot study in mice. PLOS ONE. 2013; 8(8):e70619. doi: 10.1371/journal.pone.0070619 [FI= 3.534 3.730; Times cited- 5]
  4. Lobo ML, Xiao L, Antunes F, Matos O. Microsporidia as emerging pathogens and the implication for public health: A 10-year study on HIV-positive and -negative patients. International Journal for Parasitology. 2012; 42(2):197-205. [FI= 3.872; Times cited- 25]
  5. Matos O, Lobo ML. Enterocytozoon. In: Molecular Biology of Food and Water Borne Mycotoxigenic and Mycotic Fungi of Humans. R. Russel M. Paterson (editor). Food Microbiology Series (series editor: Dongyou Liu), CRC Press, 2015, Cap. 20, pp. 293-322.

 

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok